Elsevier

Autoimmunity Reviews

Volume 3, Issue 2, 29 February 2004, Pages 69-75
Autoimmunity Reviews

Pathogenesis of hemophagocytic syndrome (HPS)

https://doi.org/10.1016/S1568-9972(03)00091-0Get rights and content

Abstract

Hemophagocytic syndrome (HPS) is a clinicopathologic entity characterized by increased proliferation and activation of benign macrophages with hemophagocytosis throughout the reticuloendothelial system. Uncontrolled T-lymphocyte activation is responsible for increased TH1 cytokines secretion such as IFN-γ, IL-12 and IL-18 that promotes macrophage activation. Genetic defects specific for cytotoxic T lymphocytes (CTL) and natural killer (NK) cells have been identified in patients with primary HPS that are responsible for altered cell death and apoptosis induction or target killing. HPS may be secondary to malignancy, infection or autoimmune disease, and mechanisms involved are poorly understood. However, in adult-onset Still's disease, juvenile chronic arthritis and probably systemic lupus erythematosus, IL-18 might play a role in initiating macrophage activation.

Introduction

Hemophagocytic syndrome (HPS) is a clinicopathologic entity characterized by high-grade fever, hepatosplenomegaly, cytopenias, high ferritin level, and increased proliferation and activation of benign macrophages with hemophagocytosis throughout the reticuloendothelial system. HPS may be primary, as observed in familial hemophagocytic lymphohistiocytosis (FHL), X-linked lymphoproliferative syndrome (XLP), Chediak-Higashi syndrome (CHS) and Griscelli syndrome (GS), or secondary to malignancy, infections, autoimmune diseases or drugs (hypersensitivity syndrome) [1]. Clinical and biological manifestations result from the secretion of huge amounts of cytokines by activated T cells and macrophages. Genetic defects involving the perforin-dependent cytotoxic process of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells have been identified in a subgroup of primary HPS.

Section snippets

Macrophages

Although HPS is characterized by proliferation and activation of macrophages with hemophagocytosis, very few studies are aimed at investigating the macrophage itself. Phenotypic markers expressed by macrophages in small series of primary HPS patients comprise complement receptors (CD35, CD21 and CD11b), CD36, and ‘activation’ markers such as CD25 and CD30, while those from patients with secondary HPS or healthy controls do not [2]. It is thus suggested that macrophages differ, at least in their

Familial hemophagocytic lymphohistiocytosis (FHL)

FHL is an autosomal recessive disease of early childhood characterized by a non-malignant accumulation and multivisceral infiltration of activated T-cells, mainly CD8+ T lymphocytes and macrophages following viral infection. Genetic studies mapped the disease associated genes either on chromosome 9q21.3–22 (FHL1 gene), or on chromosome 10q21 (FHL2 gene) but other unidentified genes are also involved [5], [6], [7]. The FHL2 gene codes for perforin, a membranolytic protein expressed in the

Natural killer (NK) cells

NK cell function is defective in FHL patients and in their parents, especially the mothers [23], [24]. This defect is more frequently observed in those with the central nervous system (CNS) involvement. Very young patients with persistently deficient NK cell activity and/or overt CNS disease are at high risk of fatal FHL [24]. In vitro cytolytic function of NK and CTL isolated from 65 patients with FHL were compared to controls. Four distinct defects in cellular cytotoxicity were described and

Cytokines, cytokine receptors and chemokines in HPS

HPS results from uncontrolled T-lymphocyte activation that promote macrophage activation and the formation of a cytokine network (Fig. 1). In patients with active HPS, serum levels of the TH1 cytokines IFN-γ [26], [27], [28], [29], [30], IL-12 [26], [27] and IL-18 [27] are significantly higher than in remission phase of the disease or in healthy controls. IL-18 seem to play a central role in inducing IFN-γ and IL-12 secretion [27] and serum levels of IFN-γ and IL-18 correlate positively with

HPS and autoimmune diseases

HPS may occur during the course of autoimmune and systemic inflammatory diseases (Table 1). In SLE, HPS may initially accompany a disease flare or occur as a consequence of an infectious complication [36]. The occurrence of HPS as part of a disease flare might result from increased IL-18 production, which is able to trigger the inflammatory processes in SLE [37]. IL-18 could also play a prominent role in AOSD, since serum IL-18 modulate ferritin synthesis in vitro by monocyte/macrophage and

References (40)

  • W. Lin et al.

    Clinical and biological significance of clonal macrophage detection in hemophagocytic syndrome

    J Huazhong Univ Sci Technol Med Sci

    (2002)
  • D.M. Mosser

    The many faces of macrophage activation

    J Leukoc Biol

    (2003)
  • S.E. Stepp et al.

    Perforin gene defects in familial hemophagocytic lymphohistiocytosis

    Science

    (1999)
  • N. Yoshida et al.

    Engraftment and dissemination of T lymphocytes from primary haemophagocytic lymphohistiocytosis in scid mice

    Br J Haematol

    (2003)
  • G. Menasche et al.

    Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome

    Natl Genet

    (2000)
  • O. Sanal et al.

    Griscelli disease: genotype–phenotype correlation in an array of clinical heterogeneity

    J Clin Immunol

    (2002)
  • M.A. Karim et al.

    Mutations in the Chediak-Higashi syndrome gene (CHS1) indicate requirement for the complete 3801 amino acid CHS protein

    Hum Mol Genet

    (1997)
  • X. Wang et al.

    Neurobeachin: a protein kinase A-anchoring, beige/Chediak-Higashi protein homolog implicated in neuronal membrane traffic

    J Neurosci

    (2000)
  • J.D. Lay et al.

    Epstein-Barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome

    J Biomed Sci

    (2003)
  • A.J. Coffey et al.

    Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene

    Natl Genet

    (1998)
  • Cited by (202)

    • Macrophagic activation syndrome revealing disseminated multifocal tuberculosis: A case report of a rare clinical situation

      2022, Annals of Medicine and Surgery
      Citation Excerpt :

      The respiratory evolution was favorable with a progressive regression of cough and dyspnea at the end of the second month. MAS, also known as a hemophagocytic syndrome, is defined by a set of clinical and biological signs related to the proliferation and histiocytic activation of the reticuloendothelial system, leading to anarchic phagocytosis of figurative blood elements and marrow precursors [1]. MAS can be either:

    • New markers for adult-onset Still's disease

      2018, Revue du Rhumatisme (Edition Francaise)
    View all citing articles on Scopus
    View full text